BNTX

An opioid receptor antagonist.

Phase of research

Potential treatment - pre-clinical evidence

How it helps

Antiviral

Drug status

Experimental

1
Supporting references
0
Contradictory references
0
AI-suggested references
0
Clinical trials

General information

BNTX is an opioid receptor antagonist (Zhang et al., 2020).

BNTX on PubChem


Synonyms

Morphinan-6-one, 17-(cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxy-7-(phenylmethylene)-, (5alpha)-

 

Structure image - BNTX

C1CC1CN2CC[C@]34[C@@H]5C(=O)/C(=C\C6=CC=CC=C6)/C[C@]3([C@H]2CC7=C4C(=C(C=C7)O)O5)O


Supporting references

Link Tested on Impact factor Notes Publication date
Heparan sulfate assists SARS-CoV-2 in cell entry and can be targeted by approved drugs in vitro
Polysaccharide Small molecule In vitro
ACE2-GFP HEK293T cells; Calu-3 cells; Vero E6 cells; SARS-CoV-2 pseudotyped particles 6.26

Inhibits SARS-CoV-2 pseudovirus cell entry with IC50 of 10 μM in ACE2-GFP HEK293T cells. At 2 μM concentration the drug reduced virus-induced cytopathic effect in Vero E6 cells by ca. 70%. It might act through actin cytoskeleton metabolism disregulation.

Nov/04/2020